Posted inHematology-Oncology news
Unveiling Non-PF4/Heparin-Binding, Platelet-Activating Antibodies in Heparin-Induced Thrombocytopenia: Implications for Diagnosis and Pathogenesis
Recent findings identify a prevalent subset of platelet-activating antibodies in HIT that evade traditional PF4/heparin ELISA detection, highlighting new diagnostic and pathogenic insights.